未登录

D

Dibyendu Dutta

state university of new york upstate medical university

H指数:19

被引数:842

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Xp22.33 Duplication Encompassing PAR1 in a Male with Syndromic Neurodevelopmental Disorder and Tall Stature

Xp22.33 包含 PAR1 的重复序列，在一例伴有综合征性神经发育障碍和身材高大的男性中。

IF2.8

2026-02-270

OAAI

ZFHX3-associated neural tube defect

BMJ CASE REPORTS

IF0.5

2025-11-010

PRE

Evidence of maternal inheritance of Nizon-Isidor syndrome in an individual with GAMT and TNFRSF13B sequence variants

Nizon-Isidor综合征母系遗传的证据：来自一名携带GAMT和TNFRSF13B序列变异个体的案例

Journal of Human Genetics

IF2.5

2025-09-160

PRE

Neurodevelopmental delay, musculoskeletal disorders and dysmorphia associated with a novel pathogenic interstitial deletion of chromosome 10q21.1q21.3

JOURNAL OF MEDICAL GENETICS

IF3.7

2025-02-040

PRE

Antibody-drug conjugates: Principles and opportunities

抗体-药物结合物: 原则和机遇

IF5.1

2024-06-013

PRE

CRISPR-based precision medicine for hematologic disorders: Advancements, challenges, and prospects

基于CRISPR的血液系统疾病精准医学: 进展、挑战与展望

IF5.1

2023-11-012

PRE

Chronic graft-versus-host disease in pediatric patients: Differences and challenges

IF5.7

2023-07-019

PRE

Intestinal barrier functions in hematologic and oncologic diseases

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2023-03-3110

OAAI

Radioimmunoconjugates in the age of modern immuno-oncology

IF5.1

2022-12-016

PRE

L-glutamine for sickle cell disease: more than reducing redox

ANNALS OF HEMATOLOGY

IF2.4

2022-05-1416

PRE

Piperacillin/Tazobactam and Meropenem Use Increases the Risks for Acute Graft Rejection Following First Kidney Transplantation

JOURNAL OF CLINICAL MEDICINE

IF2.9

2022-05-110

OAAI

L-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: Hype or hope?

IF5.7

2022-05-0126

PRE

Genes modulating intestinal permeability and microbial community are dysregulated in sickle cell disease

ANNALS OF HEMATOLOGY

IF2.4

2022-02-156

PRE

Sperm protein 17 targeting for epithelial ovarian cancer treatment in the era of modern immunoengineering

MOLECULAR THERAPY ONCOLYTICS

IF5.3

2021-12-011

OAAI

Antibiotics to modify sickle cell disease vaso-occlusive crisis?

抗生素改变镰状细胞病血管闭塞危象？

IF5.7

2021-11-012

PREAI

Allogeneic hematopoietic stem cell transplant for sickle cell disease: The why, who, and what

IF5.7

2021-11-018

PREAI

Hematopoietic Stem Cell Transplant for Sickle Cell Disease: PATIENT SELEction and Timing Based on Sickle Cell-Related Multiple Chronic Conditions

CELL TRANSPLANTATION

IF3.2

2021-10-098

OAAI

Vaso-occlusive crisis in sickle cell disease: a vicious cycle of secondary events

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2021-09-2038

OAAI

Obesity and diabetes mellitus in patients with sickle cell disease

ANNALS OF HEMATOLOGY

IF2.4

2021-06-207

PREAI

Antimicrobial therapy during cancer treatment: Beyond antibacterial effects

JOURNAL OF INTERNAL MEDICINE

IF9.2

2021-02-1216

OAAI